FDA Recalls Bevacizumab Intravitreal Injection Due to Sterility Concerns
AmEx Pharmacy is recalling Bevacizumab intravitreal injections because the product lacks assurance of sterility. The recall covers all lots remaining within expiry in the Continental U.S. and Puerto Rico.
- Product
- Bevacizumab, 1.25 mg/0.05 mL, 31G MJ Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901
- Category
- Distribution
- 1 state